feed,title,long_url,short_url
SeekingAlpha,"Cintas EPS beats by $0.43, beats on revenue",https://seekingalpha.com/news/3646597,
SeekingAlpha,KemPharm files KP879 application for stimulant use disorder,https://seekingalpha.com/news/3646596,
SeekingAlpha,Tonix nabs exclusive license for oxytocin-based treatments,https://seekingalpha.com/news/3646595,
SeekingAlpha,Q3 corporate profits,https://seekingalpha.com/news/3646594,
